AlphaMark Advisors’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,066
Closed -$254K 735
2024
Q1
$254K Buy
+4,066
New +$277K 0.09% 205
2018
Q4
Sell
-14,978
Closed -$819K 472
2018
Q3
$819K Sell
14,978
-748
-5% -$42.8K 0.33% 64
2018
Q2
$922K Sell
15,726
-5,000
-24% -$298K 0.37% 58
2018
Q1
$1.18M Sell
20,726
-2,050
-9% -$111K 0.5% 45
2017
Q4
$1.12M Sell
22,776
-1,084
-5% -$49.4K 0.44% 49
2017
Q3
$1.09M Hold
23,860
0.46% 49
2017
Q2
$932K Hold
23,860
0.4% 58
2017
Q1
$969K Sell
23,860
-10,750
-31% -$421K 0.45% 54
2016
Q4
$1.33M Buy
34,610
+7,400
+27% +$253K 0.69% 39
2016
Q3
$867K Buy
27,210
+3,300
+14% +$125K 0.44% 58
2016
Q2
$956K Sell
23,910
-6,700
-22% -$248K 0.56% 44
2016
Q1
$1.03M Sell
30,610
-19,361
-39% -$554K 0.55% 44
2015
Q4
$1.55M Buy
49,971
+21,584
+76% +$639K 0.79% 39
2015
Q3
$852K Hold
28,387
0.47% 48
2015
Q2
$897K Buy
+28,387
New +$741K 0.5% 54

Other funds holding AMN

AlphaMark Advisors's AMN Position: Q2 2024 in Review

AlphaMark Advisors sold out of AMN Healthcare (AMN) in Q2 2024, closing a stake of 4,066 shares — an estimated $254K sold.

AlphaMark Advisors first reported a position in AMN in Q2 2015 and held it in 15 quarters. The position peaked at $1.55M in Q4 2015. 328 funds tracked by Wall St. Rank hold AMN as of Q2 2024.

  • AlphaMark Advisors reported no remaining AMN Healthcare position as of Q2 2024 after selling out during the quarter.
  • AlphaMark Advisors sold 4,066 AMN Healthcare shares in Q2 2024, an estimated $254K.
  • AlphaMark Advisors first reported a position in AMN Healthcare in Q2 2015 and held it in 15 quarters.
  • AlphaMark Advisors's AMN Healthcare position peaked at $1.55M in Q4 2015.
  • 328 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2024.

Based on AlphaMark Advisors's 13F filing for Q2 2024, filed 17 Jul 2024.